+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

Prediabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Prediabetes - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Severe Hypertriglyceridemia - Pipeline Insight, 2024 - Product Thumbnail Image

Severe Hypertriglyceridemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 70 Pages
  • Global
From
Exocrine Pancreatic Insufficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Exocrine Pancreatic Insufficiency - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Dementia with Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Dementia with Diabetes - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Chronic pancreatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic pancreatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Congenital Hyperinsulinism Market - Product Thumbnail Image

Congenital Hyperinsulinism Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Type 2 Diabetes Pipeline Analysis Report - Product Thumbnail Image

Type 2 Diabetes Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
From
From
Insulin Patch Pumps Market - Product Thumbnail Image

Insulin Patch Pumps Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
From
From
Polycystic ovary syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Polycystic ovary syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Type 2 Diabetes Market 2025-2029 - Product Thumbnail Image

Type 2 Diabetes Market 2025-2029

  • Report
  • February 2025
  • 221 Pages
  • Global
From
Non-insulin Diabetes Therapeutics Market 2024-2028 - Product Thumbnail Image

Non-insulin Diabetes Therapeutics Market 2024-2028

  • Report
  • August 2024
  • 178 Pages
  • Global
From
Insulin Syringes Market 2024-2028 - Product Thumbnail Image

Insulin Syringes Market 2024-2028

  • Report
  • July 2024
  • 139 Pages
  • Global
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more